Sofinnova Investments, Inc. Q2 2022 Filing
Filed August 15, 2022
Portfolio Value
$1.2T
Holdings
56
Report Date
Q2 2022
Filing Type
13F-HR
All Holdings (56 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | KRTXKaruna Therapeutics Inc | 2,073,124 | $262.3B | 21.84% | |
| 2 | NTRANatera Inc | 3,102,960 | $110.0B | 9.16% | |
| 3 | —Cincor Pharma Inc | 5,573,949 | $105.0B | 8.75% | |
| 4 | AVTEAerovate Therapeutics Inc | 3,758,686 | $58.7B | 4.89% | |
| 5 | ASNDAscendis Pharma A/S | 499,824 | $46.5B | 3.87% | |
| 6 | VERAVera Therapeutics Inc | 3,181,442 | $43.3B | 3.61% | |
| 7 | XLVHealth Care Select Sector SPDR Fund | 300,000 | $38.5B | 3.20% | Put |
| 8 | YMABUSDY-mAbs Therapeutics Inc | 2,194,278 | $33.2B | 2.76% | |
| 9 | MRKMerck & Co Inc | 360,961 | $32.9B | 2.74% | |
| 10 | NVONovo-Nordisk A S | 273,873 | $30.5B | 2.54% | |
| 11 | XBISPDR S&P Biotech ETF | 400,000 | $29.7B | 2.47% | Put |
| 12 | UTHUnited Therapeutics Corp | 106,379 | $25.1B | 2.09% | |
| 13 | BMRNBiomarin Pharmaceutical Inc | 301,605 | $25.0B | 2.08% | |
| 14 | RETAEURReata Pharmaceuticals Inc | 783,851 | $23.8B | 1.98% | |
| 15 | CCXIEURChemoCentryx Inc | 886,659 | $22.0B | 1.83% | Call |
| 16 | VRTXVertex Pharmaceuticals Inc | 74,758 | $21.1B | 1.75% | |
| 17 | AZNAstraZeneca PLC | 316,360 | $20.9B | 1.74% | |
| 18 | RGNXRegenxbio Inc | 776,624 | $19.2B | 1.60% | |
| 19 | INZYInozyme Pharm Inc | 3,655,308 | $17.4B | 1.45% | |
| 20 | CTIC1USDCTI Biopharma Corp | 2,704,510 | $16.1B | 1.34% | |
| 21 | IRTCiRhythm Technologies Inc | 142,091 | $15.3B | 1.28% | |
| 22 | SNYSanofi SA | 282,200 | $14.1B | 1.18% | |
| 23 | DC4Dexcom Inc | 189,092 | $14.1B | 1.17% | |
| 24 | CYTKCytokinetics Inc | 320,780 | $12.6B | 1.05% | |
| 25 | NXTCNextcure Inc | 2,671,856 | $12.6B | 1.05% | |
| 26 | IMTXImmatics NV | 1,294,103 | $11.3B | 0.94% | |
| 27 | —Prometheus Biosciences Inc | 386,395 | $10.9B | 0.91% | |
| 28 | SRPTSarepta Therapeutics Inc | 131,245 | $9.8B | 0.82% | |
| 29 | ZNTLZentalis Pharmaceuticals Inc | 328,397 | $9.2B | 0.77% | |
| 30 | HZNPHorizon Therapeutics PLC | 100,297 | $8.0B | 0.67% | |
| 31 | SNDXSyndax Pharmaceuticals Inc | 413,428 | $8.0B | 0.66% | |
| 32 | —ObsEva SA | 4,749,623 | $7.6B | 0.64% | |
| 33 | TORCEURAdicet Bio Inc | 518,379 | $7.6B | 0.63% | |
| 34 | —Akouos Inc | 1,515,074 | $7.1B | 0.59% | |
| 35 | OPHTEURIveric Bio Inc | 653,047 | $6.3B | 0.52% | |
| 36 | GONGeron Corp | 3,791,630 | $5.9B | 0.49% | Call |
| 37 | ARGXargenx SE | 15,000 | $5.7B | 0.47% | |
| 38 | BOLT1EURBolt Biotherapeutics Inc | 2,754,437 | $5.6B | 0.47% | |
| 39 | TVTXTravere Therapeutics Inc | 212,593 | $5.2B | 0.43% | |
| 40 | IMGNEURImmunoGen Inc | 1,140,788 | $5.1B | 0.43% | |
| 41 | SGENUSDSeagen Inc | 27,894 | $4.9B | 0.41% | |
| 42 | 290AChinook Therapeutics Inc | 276,609 | $4.8B | 0.40% | |
| 43 | XNCRXencor Inc | 158,164 | $4.3B | 0.36% | |
| 44 | —Nucana Biomed | 5,599,999 | $4.1B | 0.34% | |
| 45 | GRTXGalera Therapeutics Inc | 3,083,712 | $4.0B | 0.33% | |
| 46 | AMLXAmylyx Pharmaceuticals Inc | 187,381 | $3.6B | 0.30% | |
| 47 | JNCEEURJounce Therapeutics Inc | 981,928 | $3.0B | 0.25% | |
| 48 | AGENEURAgenus Inc | 952,742 | $1.8B | 0.15% | |
| 49 | —Nucana Biomed | 2,400,000 | $1.7B | 0.14% | |
| 50 | INBXUSDInhibrx Inc | 147,935 | $1.7B | 0.14% | |
| 51 | TCE2Celldex Therapeutics Inc | 48,304 | $1.3B | 0.11% | |
| 52 | PTGXProtagonist Therapeutics Inc | 100,000 | $791.0M | 0.07% | Call |
| 53 | —Synlogic Inc | 574,972 | $661.0M | 0.06% | |
| 54 | PDSBPDS Biotechnology Corporation | 142,635 | $521.0M | 0.04% | |
| 55 | —Fusion Pharmaceuticals Inc | 78,066 | $194.0M | 0.02% | |
| 56 | IM8NInsmed Inc | 7,370 | $145.0M | 0.01% |